Osteopontin as a two-sided mediator in acute neuroinflammation in rat models

Acta Histochemica

Volumn 114, Issue 8, 2012, Pages 749-754

  Shin, Taekyun ^a  

^a Jeju National University   (South Korea)

Author keywords

Macrophages; Neuroinflammation; Neuroprotection; Osteopontin; Rat model

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; OSTEOPONTIN; SMALL INTERFERING RNA;

ALLERGIC ENCEPHALOMYELITIS; AUTOIMMUNE DISEASE; BRAIN HEMORRHAGE; BRAIN INJURY; CELLULAR DISTRIBUTION; CHEMOTAXIS; COLD INJURY; DENDRITIC CELL; DRUG MECHANISM; EXPERIMENTAL RAT; INNATE IMMUNITY; MACROPHAGE; NERVE CELL; NERVOUS SYSTEM INFLAMMATION; NEURITIS; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION; SUBARACHNOID HEMORRHAGE; T LYMPHOCYTE;

ACUTE DISEASE; ANIMALS; BRAIN INJURIES; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; INFLAMMATION; INFLAMMATION MEDIATORS; NEURITIS, AUTOIMMUNE, EXPERIMENTAL; OSTEOPONTIN; RATS;

RATTUS;

EID: 84867142016     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2012.08.004     Document Type: Review

References (58)

1. Abel B., Kurrer M., Shamshiev A., Marty R.R., Eriksson U., Gunthert U., et al. The osteopontin - CD44 pathway is superfluous for the development of autoimmune myocarditis. Eur J Immunol 2006, 36:494-499.
2. Ahn M., Lee Y., Moon C., Jin J.K., Matsumoto Y., Koh C.S., et al. Upregulation of osteopontin in Schwann cells of the sciatic nerves of Lewis rats with experimental autoimmune neuritis. Neurosci Lett 2004, 372:137-141.
3. Ahn M., Moon C., Kim H., Lee J., Sung Koh C., Matsumoto Y., et al. Immunohistochemical study of caveolin-1 in the sciatic nerves of Lewis rats with experimental autoimmune neuritis. Brain Res 2006, 1102:86-91.
4. Ahn M., Moon C., Lee Y., Koh C.S., Kohyama K., Tanuma N., et al. Activation of extracellular signal-regulated kinases in the sciatic nerves of rats with experimental autoimmune neuritis. Neurosci Lett 2004, 372:57-61.
5. Ahn M., Shin T. Increased phosphorylation of c-Jun NH (2)-terminal protein kinase in the sciatic nerves of Lewis rats with experimental autoimmune neuritis. J Vet Sci 2006, 7:13-17.
6. Ahn M., Yang W., Kim H., Jin J.K., Moon C., Shin T. Immunohistochemical study of arginase-1 in the spinal cords of Lewis rats with experimental autoimmune encephalomyelitis. Brain Res 2012, 1453:77-86.
7. Anborgh P.H., Mutrie J.C., Tuck A.B., Chambers A.F. Role of the metastasis-promoting protein osteopontin in the tumour microenvironment. J Cell Mol Med 2010, 14:2037-2044.
8. Braitch M., Constantinescu C.S. The role of osteopontin in experimental autoimmune encephalomyelitis (EAE) and multiple sclerosis (MS). Inflamm Allergy Drug Targets 2010, 9:249-256.
9. Buback F., Renkl A.C., Schulz G., Weiss J.M. Osteopontin and the skin: multiple emerging roles in cutaneous biology and pathology. Exp Dermatol 2009, 18:750-759.
10. Chabas D., Baranzini S.E., Mitchell D., Bernard C.C., Rittling S.R., Denhardt D.T., et al. The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science 2001, 294:1731-1735.
11. Chen H.T., Tsou H.K., Chang C.H., Tang C.H. Hepatocyte growth factor increases osteopontin expression in human osteoblasts through PI3K, Akt, c-Src, and AP-1 signaling pathway. PLoS ONE 2012, 7:e38378.
12. Chen W., Ma Q., Suzuki H., Hartman R., Tang J., Zhang J.H. Osteopontin reduced hypoxia-ischemia neonatal brain injury by suppression of apoptosis in a rat pup model. Stroke 2011, 42:764-769.
13. Fu G.X., Xu C.C., Zhong Y., Zhu D.L., Gao P.J. Aldosterone-induced osteopontin expression in vascular smooth muscle cells involves MR, ERK, and p38 MAPK. Endocrine 2012.
14. Guo H., Wai P.Y., Mi Z., Gao C., Zhang J., Kuo P.C. Osteopontin mediates Stat1 degradation to inhibit iNOS transcription in a cecal ligation and puncture model of sepsis. Surgery 2008, 144:182-188.
15. Heilmann K., Hoffmann U., Witte E., Loddenkemper C., Sina C., Schreiber S., et al. Osteopontin as two-sided mediator of intestinal inflammation. J Cell Mol Med 2009, 13:1162-1174.
16. Hur E.M., Youssef S., Haws M.E., Zhang S.Y., Sobel R.A., Steinman L. Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cells. Nat Immunol 2007, 8:74-83.
17. Inoue M., Shinohara M.L. Intracellular osteopontin (iOPN) and immunity. Immunol Res 2011, 49:160-172.
18. Jander S., Bussini S., Neuen-Jacob E., Bosse F., Menge T., Muller H.W., et al. Osteopontin: a novel axon-regulated Schwann cell gene. J Neurosci Res 2002, 67:156-166.
19. Jansson M., Panoutsakopoulou V., Baker J., Klein L., Cantor H. Cutting edge: attenuated experimental autoimmune encephalomyelitis in eta-1/osteopontin-deficient mice. J Immunol 2002, 168:2096-2099.
20. Kalluri H.S., Dempsey R.J. Osteopontin increases the proliferation of neural progenitor cells. Int J Dev Neurosci 2012, 30:359-362.
21. Kang W.S., Choi J.S., Shin Y.J., Kim H.Y., Cha J.H., Lee J.Y., et al. Differential regulation of osteopontin receptors, CD44 and the alpha(v) and beta(3) integrin subunits, in the rat hippocampus following transient forebrain ischemia. Brain Res 2008, 1228:208-216.
22. Kazanecki C.C., Uzwiak D.J., Denhardt D.T. Control of osteopontin signaling and function by post-translational phosphorylation and protein folding. J Cell Biochem 2007, 102:912-924.
23. Kim H., Moon C., Ahn M., Matsumoto Y., Koh C.S., Kim M.D., et al. Increased phosphorylation of caveolin-1 in the sciatic nerves of Lewis rats with experimental autoimmune neuritis. Brain Res 2007, 1137:153-160.
24. Kim M.D., Cho H.J., Shin T. Expression of osteopontin and its ligand, CD44, in the spinal cords of Lewis rats with experimental autoimmune encephalomyelitis. J Neuroimmunol 2004, 151:78-84.
25. Lee Y., Shin T. Expression of constitutive endothelial and inducible nitric oxide synthase in the sciatic nerve of Lewis rats with experimental autoimmune neuritis. J Neuroimmunol 2002, 126:78-85.
26. McKee M.D., Pedraza C.E., Kaartinen M.T. Osteopontin and wound healing in bone. Cells Tissues Organs 2011, 194:313-319.
27. Moon C., Ahn M., Kim H., Lee Y., Koh C.S., Matsumoto Y., et al. Activation of p38 mitogen-activated protein kinase in the early and peak phases of autoimmune neuritis in rat sciatic nerves. Brain Res 2005, 1040:208-213.
28. Moon C., Ahn M., Kim S., Jin J.K., Sim K.B., Kim H.M., et al. Temporal patterns of the embryonic intermediate filaments nestin and vimentin expression in the cerebral cortex of adult rats after cryoinjury. Brain Res 2004, 1028:238-242.
29. Moon C., Heo S., Ahn M., Kim H., Shin M., Sim K.B., et al. Immunohistochemical study of osteopontin in the spinal cords of rats with clip compression injury. J Vet Med Sci 2004, 66:1307-1310.
30. Moon C., Shin T. Increased expression of osteopontin in the spinal cords of Lewis rats with experimental autoimmune neuritis. J Vet Sci 2004, 5:289-293.
31. Murugaiyan G., Mittal A., Weiner H.L. Increased osteopontin expression in dendritic cells amplifies IL-17 production by CD4+ T cells in experimental autoimmune encephalomyelitis and in multiple sclerosis. J Immunol 2008, 181:7480-7488.
32. Niino M., Kikuchi S. Osteopontin and multiple sclerosis: an update. Clin Exp Neuroimmunol 2011, 2:33-40.
33. O'Regan A. The role of osteopontin in lung disease. Cytokine Growth Factor Rev 2003, 14:479-488.
34. Park J.M., Shin Y.J., Kim H.L., Cho J.M., Lee M.Y. Sustained expression of osteopontin is closely associated with calcium deposits in the rat hippocampus after transient forebrain ischemia. J Histochem Cytochem 2012, 60:550-559.
35. Plantman S. Osteopontin is upregulated after mechanical brain injury and stimulates neurite growth from hippocampal neurons through beta1 integrin and CD44. Neuroreport 2012, 23:647-652.
36. Rittling S.R. Osteopontin in macrophage function. Expert Rev Mol Med 2011, 13:e15.
37. Rittling S.R., Chambers A.F. Role of osteopontin in tumour progression. Br J Cancer 2004, 90:1877-1881.
38. Rollo E.E., Laskin D.L., Denhardt D.T. Osteopontin inhibits nitric oxide production and cytotoxicity by activated RAW264.7 macrophages. J Leukocyte Biol 1996, 60:397-404.
39. Schroeter M., Zickler P., Denhardt D.T., Hartung H.P., Jander S. Increased thalamic neurodegeneration following ischaemic cortical stroke in osteopontin-deficient mice. Brain 2006, 129:1426-1437.
40. Shin T., Ahn M., Jung K., Heo S., Kim D., Jee Y., et al. Activation of mitogen-activated protein kinases in experimental autoimmune encephalomyelitis. J Neuroimmunol 2003, 140:118-125.
41. Shin T., Ahn M., Kim H., Kim H.M., Matsumoto Y. Increased expression of osteopontin in the heart tissue of Lewis rats with experimental autoimmune myocarditis. J Vet Med Sci 2006, 68:379-382.
42. Shin T., Ahn M., Kim H., Moon C., Kang T.Y., Lee J.M., et al. Temporal expression of osteopontin and CD44 in rat brains with experimental cryolesions. Brain Res 2005, 1041:95-101.
43. Shin T., Kim H., Jin J.K., Moon C., Ahn M., Tanuma N., et al. Expression of caveolin-1, -2, and -3 in the spinal cords of Lewis rats with experimental autoimmune encephalomyelitis. J Neuroimmunol 2005, 165:11-20.
44. Shin T., Kojima T., Tanuma N., Ishihara Y., Matsumoto Y. The subarachnoid space as a site for precursor T cell proliferation and effector T cell selection in experimental autoimmune encephalomyelitis. J Neuroimmunol 1995, 56:171-178.
45. Shin Y.J., Kim H.L., Choi J.S., Choi J.Y., Cha J.H., Lee M.Y. Osteopontin: correlation with phagocytosis by brain macrophages in a rat model of stroke. Glia 2011, 59:413-423.
46. Sodek J., Ganss B., McKee M.D. Osteopontin. Crit Rev Oral Biol Med 2000, 11:279-303.
47. Suzuki H., Hasegawa Y., Kanamaru K., Zhang J.H. Mechanisms of osteopontin-induced stabilization of blood-brain barrier disruption after subarachnoid hemorrhage in rats. Stroke 2010, 41:1783-1790.
48. Takahashi F., Takahashi K., Maeda K., Tominaga S., Fukuchi Y. Osteopontin is induced by nitric oxide in RAW 264.7 cells. IUBMB Life 2000, 49:217-221.
49. Uede T. Osteopontin, intrinsic tissue regulator of intractable inflammatory diseases. Pathol Int 2011, 61:265-280.
50. Wai P.Y., Guo L., Gao C., Mi Z., Guo H., Kuo P.C. Osteopontin inhibits macrophage nitric oxide synthesis to enhance tumor proliferation. Surgery 2006, 140:132-140.
51. Wang K.X., Denhardt D.T. Osteopontin: role in immune regulation and stress responses. Cytokine Growth Factor Rev 2008, 19:333-345.
52. Wang X., Louden C., Yue T.L., Ellison J.A., Barone F.C., Solleveld H.A., et al. Delayed expression of osteopontin after focal stroke in the rat. J Neurosci 1998, 18:2075-2083.
53. Weber G.F. The cancer biomarker osteopontin: combination with other markers. Cancer Genomics Proteomics 2011, 8:263-288.
54. Wu B., Ma Q., Suzuki H., Chen C., Liu W., Tang J., et al. Recombinant osteopontin attenuates brain injury after intracerebral hemorrhage in mice. Neurocrit Care 2011, 14:109-117.
55. Xie Y., Sakatsume M., Nishi S., Narita I., Arakawa M., Gejyo F. Expression, roles, receptors, and regulation of osteopontin in the kidney. Kidney Int 2001, 60:1645-1657.
56. Yan Y.P., Lang B.T., Vemuganti R., Dempsey R.J. Osteopontin is a mediator of the lateral migration of neuroblasts from the subventricular zone after focal cerebral ischemia. Neurochem Int 2009, 55:826-832.
57. Zhao W., Wang L., Zhang L., Yuan C., Kuo P.C., Gao C. Differential expression of intracellular and secreted osteopontin isoforms by murine macrophages in response to toll-like receptor agonists. J Biol Chem 2010, 285:20452-20461.
58. Zohar R., Suzuki N., Suzuki K., Arora P., Glogauer M., McCulloch C.A., et al. Intracellular osteopontin is an integral component of the CD44-ERM complex involved in cell migration. J Cell Physiol 2000, 184:118-130.